Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2004
10/14/2004WO2004088310A1 Comparative genomic hybridization
10/14/2004WO2004088309A2 Methods for diagnosing urinary tract and prostatic disorders
10/14/2004WO2004088308A1 Method for inducing an inflammatory response in pulmonary disease and its use in the screening for agents
10/14/2004WO2004088307A2 Detection method for the expression of recombinant proteins on a cell surface and for the immobilization and purification of cells and proteins
10/14/2004WO2004088306A1 Method for the determination of dissolved and colloidal disturbing substances in a papermaking process
10/14/2004WO2004088305A1 Photoelectrochemical determination of chemical oxygen demand
10/14/2004WO2004088304A2 Method and device for utilizing analyte levels to assist in the treatment of diabetes, insulin resistance and metabolic syndrome
10/14/2004WO2004088298A1 Cavity electrode structure, sensor using same, and protein detection device
10/14/2004WO2004088292A1 Apparatus for measuring uniformity of a laminar materiel
10/14/2004WO2004088283A2 Apparatus and methods for providing sex-sorted animal sperm
10/14/2004WO2004088282A2 Methods to control and/or predict rheological properties
10/14/2004WO2004088280A2 Method and apparatus for improved gas detection
10/14/2004WO2004088279A2 Allosteric probes and methods
10/14/2004WO2004088276A2 A method and kit for detecting the early onset of renal tubular cell injury
10/14/2004WO2004088274A2 Psychoactive compound associated markers and method of use thereof
10/14/2004WO2004088273A2 Method of monitoring the operation of gas sensor and system therefor
10/14/2004WO2004088272A2 Methods to identify biologically active agents and synergistic combinations
10/14/2004WO2004087966A2 Genomic profiling of regulatory factor binding sites
10/14/2004WO2004087965A2 Statistical analysis of regulatory factor binding sites of differentially expressed genes
10/14/2004WO2004087956A2 Cell lines for the functional expression of nav1.8
10/14/2004WO2004087955A1 Markers for roscovitine
10/14/2004WO2004087948A1 Single nucleotide polymorphisms for the diagnosis and treatment of schizophrenia spectrum disorders
10/14/2004WO2004087946A2 Method for the detection of post-translational modification activities and device system for carrying out said method
10/14/2004WO2004087945A1 Method of determining content of triglyceride in low-density lipoprotein
10/14/2004WO2004087944A1 Improvements in or relating to viability
10/14/2004WO2004087933A2 A novel encoding method for 'one-bead one-compound' combinatorial libraries
10/14/2004WO2004087925A1 Modified beta-lactamases and uses thereof
10/14/2004WO2004087921A1 Human solid cancer antigen peptides, polynucleotides encoding the same and utilization thererof
10/14/2004WO2004087919A1 Method of obtaining aptamer with the use of microarray
10/14/2004WO2004087887A2 Intracellular complexes as biomarkers
10/14/2004WO2004087884A2 TARGETING ENZYMES OF THE tRNA SPLICING PATHWAY FOR IDENTIFICATION OF ANTI-FUNGAL AND/OR ANTI-PROLIFERATIVE MOLECULES
10/14/2004WO2004087866A2 Methods for the identification of inhibitors of lipid transfer protein activity in plants
10/14/2004WO2004087865A2 The preparation and application of ligand-biopolymer conjugates
10/14/2004WO2004087863A2 Non-invasive prenatal genetic diagnosis using transcervical cells
10/14/2004WO2004087765A1 Titanium dioxide complex having molecule distinguishability
10/14/2004WO2004087764A1 Recombinant antibody recognizing dioxin and gene encoding the antibody
10/14/2004WO2004087760A1 Antibodies directed against hepatitis c virus e1e2 complex, compositions of hcv particles, and pharmaceutical compositions
10/14/2004WO2004087758A2 Il 13 receptor alpha 2 antibody and methods of use
10/14/2004WO2004087751A1 Dystrophin-related protein (drop1), a marker for carcinomas
10/14/2004WO2004087746A2 Staphylococcus epidermidis antigens
10/14/2004WO2004087745A1 Analytical method and kit thereof
10/14/2004WO2004087744A2 Composition and method for nerve regeneration
10/14/2004WO2004087737A2 Omega-3 fatty acid assays for disease risk assessment
10/14/2004WO2004087505A2 Dual-opening sample containers, fluid sampling device and method of using same
10/14/2004WO2004087421A1 Pressure control system for printing a viscous material
10/14/2004WO2004087323A1 Multi-array systems and methods of use thereof
10/14/2004WO2004087308A1 Method of synthesis and testing of combinatorial libraries using microcapsules
10/14/2004WO2004087303A1 Target detecting device and target capturer, molecule adsorption/desorption device and molecule adsoprtion/desoption method, and protein detecting device and protein detecting method
10/14/2004WO2004087299A2 Liquid absorptometry method of providing product consistency
10/14/2004WO2004087281A2 Implementation of microfluidic components, including molecular fractionation devices, in a microfluidic system
10/14/2004WO2004087259A2 Pharmaceutical composition effective in treatment of mechanical allodynia, screening method of potential compound as said pharmaceutical composition, abd inspection method of mechanical allodynia
10/14/2004WO2004087217A1 An animal model of schizophrenia
10/14/2004WO2004087205A1 Cytotoxicity mediation of cells evidencing surface expression of gp96 or precursors thereof
10/14/2004WO2004087198A1 Use of coagulation proteins to lyse clots
10/14/2004WO2004087195A2 Therapeutic use of modulators of notch and/or kruppel-like factors
10/14/2004WO2004087177A1 Process for the staining of sperm
10/14/2004WO2004087162A1 Uses of tryprostatin for the reversal of cancer drug resistance
10/14/2004WO2004087124A1 Compounds having serotonin 5-ht17 receptor antagonist activity and muscarinic m4 receptor agonist activity and their use in the treatment of psychotic disorders
10/14/2004WO2004087070A2 METHODS OF IDENTIFYING COMPOUNDS THAT TARGET tRNA SPLICING ENDONUCLEASE AND USES OF SAID COMPOUNDS AS ANTI-FUNGAL AGENTS
10/14/2004WO2004087069A2 METHODS OF IDENTIFYING COMPOUNDS THAT TARGET tRNA SPLICING ENDONUCLEASE AND USES OF SAID COMPOUNDS AS ANTI-PROLIFERATIVE AGENTS
10/14/2004WO2004087049A2 Selective activation of cellular activities mediated through a common toll-like receptor
10/14/2004WO2004087044A2 Drug target
10/14/2004WO2004086953A2 Method for diagnosis and treatment of bone turnover
10/14/2004WO2004086937A2 Methods of detecting cancer cells in biological samples
10/14/2004WO2004086858A1 Model animal of normal-pressure glaucoma
10/14/2004WO2004077007A3 Detection, quantification and composition for cytochrome c released from mitochondria
10/14/2004WO2004072232A9 Covalent tethering of functional groups to proteins
10/14/2004WO2004071392A8 Diagnostics and therapeutics for diseases associated with acetylcholine receptor, muscarinic 4(m4)
10/14/2004WO2004068137A3 Methods and device for in vitro detection and characterization of psychoactives using analysis of repetitive electrical activity in a neuronal sample
10/14/2004WO2004067162A3 Apparatus for microfluidic processing and reading of biochip arrays
10/14/2004WO2004063394A3 Uses of substances binding to fabp4 for diagnosing and treating bladder carcinoma
10/14/2004WO2004059305A3 Printed board for the electrochemical detection of biomolecules
10/14/2004WO2004054431A3 Tests for the rapid evaluation of ischemic states and kits
10/14/2004WO2004048567A3 Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites
10/14/2004WO2004047623A3 Methods for identifying risk of breast cancer and treatments thereof
10/14/2004WO2004046182A3 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases
10/14/2004WO2004045376A3 Screening methods to identify treatments for autoimmune disease
10/14/2004WO2004044229A3 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A2 (PDE7a2)
10/14/2004WO2004043988A3 Ptprk immunogenic peptide
10/14/2004WO2004041152A3 Antigenic targets of autoimmune sensorineural hearing loss (aisnhl) and development of tests fro diagnosis and management of aisnhl
10/14/2004WO2004033667A3 Detection, localization and staging of tumors using labeled activated lymphocytes directed to a tumor specific epitope
10/14/2004WO2004031775A3 Method for treating or preventing metastasis of colorectal cancers
10/14/2004WO2004031774A3 Method for treating or preventing metastasis of colorectal cancers
10/14/2004WO2004031233A3 Novel chemokine-like polypeptides
10/14/2004WO2004029621A3 Tcell mediator/modulator assay based upon tcell restricted transgenic mouse
10/14/2004WO2004025303A3 Isoprostanes as markers of psychological stress in humans
10/14/2004WO2004025244A3 Protein arrays and uses thereof
10/14/2004WO2004024063A3 Compositions and methods for the diagnosis and treatment of tumor
10/14/2004WO2004021010A3 Method of diagnosing colon and gastric cancers
10/14/2004WO2004016769A3 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof
10/14/2004WO2004015130A3 Modulators of rabggt and methods of use thereof
10/14/2004WO2004008105A3 Detection of ligand/antiligand complex formation by electromagnetically detectable bulk property measurement
10/14/2004WO2004003565A3 A screening method and compounds for treating friedreich ataxia
10/14/2004WO2004003508A3 Magnetic nanomaterials and methods for detection of biological materials
10/14/2004WO2003104811A3 Diagnostic and therapeutic use of steroidogenic acute regulatory protein for neurodegenerative diseases
10/14/2004WO2003104282A3 Glycoprotein vi - fc fusion protein for treating vascular disorders
10/14/2004WO2003091395A3 Inhibition of immune complex formation
10/14/2004WO2003089620A3 Phospholipases, nucleic acids encoding them and methods for making and using them
10/14/2004WO2003088090A3 System and method for data analysis, manipulation, and visualization
10/14/2004WO2003087135A3 Novel pheromone receptor